Menlo Park, CA, United States of America

Barry Calvarese

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Barry Calvarese: Innovator in Dermatological Treatments

Introduction

Barry Calvarese is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of dermatology through his innovative research and development of treatments for skin disorders. With a total of two patents to his name, Calvarese has focused on improving the efficacy of existing medications.

Latest Patents

Calvarese's latest patents include groundbreaking work on Azithromycin for the treatment of skin disorders. This formulation has demonstrated increased efficacy in treating acne and other skin conditions when administered systemically at low doses, which are below those previously known to produce a clinical antibiotic effect. Additionally, he has developed Azithromycin specifically for the treatment of nodular acne, proving to be an effective solution for nodules associated with acne vulgaris.

Career Highlights

Calvarese is currently employed at Dow Pharmaceutical Sciences, Inc., where he continues to innovate in the field of dermatological treatments. His work has not only advanced medical knowledge but has also provided new options for patients suffering from skin disorders.

Collaborations

Throughout his career, Calvarese has collaborated with esteemed colleagues, including David W. Osborne and Gordon J. Dow. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Barry Calvarese stands out as a significant figure in the realm of dermatological innovation. His contributions through patents and collaborations have the potential to improve the lives of many individuals dealing with skin disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…